Pharmaceutical composition for preventing and treating bovine infectious meningoenphalitis and preparation method thereof

A technology of meningoencephalitis and composition, which is applied in the field of pharmaceutical composition for preventing and treating bovine infectious meningoencephalitis and its preparation, can solve the problems of large toxic and side effects, delayed disease, side effects of body immunity, etc., and achieves non-toxic and side effects, Short course of treatment, immune-boosting effect

Inactive Publication Date: 2016-08-03
YANTAI MINWANG ELECTROMECHANICAL TECH CO LTD
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0012] The current treatment of bovine infectious meningoencephalitis is not effective, and may even delay the disease and expand the scope of infection of sick cattle
Moreover, the long-term application of chemically synthesized drugs has large toxic and side effects and high drug residues. Consumers eating this type of beef will have side effects on their body immunity.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0056] The dosage form of the pharmaceutical composition is powder injection, and its preparation method comprises the following steps:

[0057] In the first step, the raw medicinal materials are mixed in proportion, put into an ultrafine pulverizer and pulverized into a mixture composed of micron-sized particles with a volume average particle size of 0.1-10 μm and nano-sized particles with a volume-average particle size of less than 0.1 μm Powder, the powder yield of the mixed powder is at least 95%;

[0058] In the second step, add ethanol with an alcohol concentration of 85% to 95% relative to the mass of the mixed powder that is 3 to 5 times the mass of the mixed powder obtained in the first step, stir and dissolve to obtain an ethanol solution, and put the ethanol solution in Stand still for 24-36 hours under the condition of 5°C-10°C, use the percolation method to slowly percolate at a rate of 1-2ml per minute, collect the percolation liquid, concentrate and dry, and put...

Embodiment 1

[0066] Embodiment 1 pharmaceutical composition 1

[0067] The embodiment of the present invention provides a pharmaceutical composition for preventing and treating bovine transmissible meningoencephalitis, which is made of the following raw materials in parts by weight: 15 parts by weight of Herb Rhizome, 28 parts by weight of Gorgon Seed Leaf, 20 parts by weight of Coptidis Rhizoma, 32 parts by weight of Shiwei Ye, 40 parts by weight of Ganoderma lucidum, 16 parts by weight of Scallops, 33 parts by weight of Tibetan aster, 20 parts by weight of basil root, 16 parts by weight of stachyus glabra, 32 parts by weight of fairy silk, 24 parts by weight of Polygonatum odoratum, 3 parts by weight of pterygium, 18 parts by weight of Badu powder, 14 parts by weight of Hemengye, 25 parts by weight of celery, 16 parts by weight of Panax notoginseng, 32 parts by weight of variegated orchid, 24 parts by weight of chicory and 15 parts by weight of gardenia share;

[0068] In the first step...

Embodiment 2

[0071] Embodiment 2 pharmaceutical composition 2

[0072] The embodiment of the present invention provides a pharmaceutical composition for preventing and treating bovine transmissible meningoencephalitis, which is made of the following raw materials in parts by weight: 15 parts by weight of Herb Rhizome, 28 parts by weight of Gorgon Seed Leaf, 20 parts by weight of Coptidis Rhizoma, 32 parts by weight of Shiwei Ye, 40 parts by weight of Ganoderma lucidum, 16 parts by weight of Scallops, 33 parts by weight of Tibetan aster, 20 parts by weight of basil root, 16 parts by weight of stachyus glabra, 32 parts by weight of fairy silk, 24 parts by weight of Polygonatum odoratum, 3 parts by weight of pterygium, 18 parts by weight of Badu powder, 14 parts by weight of Hemengye, 25 parts by weight of celery, 16 parts by weight of Panax notoginseng, 32 parts by weight of variegated orchid, 24 parts by weight of chicory, 15 parts by weight of gardenia 12 parts by weight, 12 parts by weigh...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a pharmaceutical composition for preventing and treating bovine infectious meningoenphalitis and a preparation method thereof .The pharmaceutical composition is prepared from large leaf moss, gordon euryale leaves, coptis chinensis, walton's lepisorus, lucid ganoderma, embelia ribes, stephania sinica diels, allium macrostemon, asteris souliei, basil roots, hedge nettle, biondia henryi, radix polygonati officinalis, pterocephalus hookeri heck, sida szechuensis, sensitive joint vetch leaves, Cryptotaenia japonica, pseudo-ginseng, rattlesnake plantain, chicories, jasmine, herb of dense flower bulbophyllum, wall fern and neroli .The pharmaceutical composition has the advantages that the effects of achieving antisepsis and anti-inflammation, clearing away heat and toxic materials, soothing the nerves, achieving tranquilization, regulating vital energy and invigorating the stomach are achieved when the pharmaceutical composition is used for preventing and treating bovine infectious meningoenphalitis, the bovine immunity is enhanced to a certain degree, the curative ratio is high, the effect can be taken rapidly, the treatment course is short, and no toxic or side effect exists .

Description

technical field [0001] The invention relates to the field of veterinary medicine, in particular to a pharmaceutical composition for preventing and treating bovine infectious meningoencephalitis and a preparation method thereof. Background technique [0002] Bovine infectious meningoencephalitis, also known as bovine infectious thromboembolic meningoencephalitis, is a bovine disease characterized by meningoencephalitis, pneumonia, and arthritis. The pathogen is Haemophilus somniferus. [0003] Symptoms of bovine infectious meningoencephalitis: meningoencephalitis, pneumonia, arthritis and other pathogens. [0004] Many encephalopathy are accompanied by meningeal damage. Inflammation starts as hyperemia, characterized by increased excitability, and later becomes inhibited due to severe damage to the brain parenchyma by pathogenic microorganisms and their toxins. [0005] Etiology of bovine infectious meningoencephalitis: caused by infection and poisoning. Improper feeding ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/898A61P31/04A61P25/00
CPCA61K36/10A61K9/0019A61K9/19A61K36/074A61K36/11A61K36/185A61K36/23A61K36/258A61K36/27A61K36/28A61K36/48A61K36/53A61K36/59A61K36/62A61K36/718A61K36/744A61K36/752A61K36/8962A61K36/8969A61K36/898A61K2236/331A61K2236/333A61K2236/39A61K2236/55A61K2300/00
Inventor 鲁俊廷
Owner YANTAI MINWANG ELECTROMECHANICAL TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap